Skip to main content
. 2016 Dec 7;6(12):160254. doi: 10.1098/rsob.160254

Table 3.

Clinical biomarkers for breast cancer.

molecular subtype biomakers treatment
hormone receptor Ki67 index tamoxifen
hormone receptor expression
loss of ER positivity
HER2+ loss of HER2 monoclonal antibody
gain of ER positivity
triple negative gene mutations CMF or CEF adjuvant chemotherapy